Bringing the fundamentals into focus…
Back to Rigel Pharmaceuticals, Inc.
How Rigel Pharmaceuticals, Inc. stacks up
RIGL · against 442 other Healthcare companies of similar size
Growth
88/ 100
Near the top of its peers.
Ranked #43 of 443 · scores higher than 90% of peers
Bars: peers in each 10-point band of the growth score38 peers with a growth score of 80–89, including RIGL · Click a bar to see the companies
Why growth scores 88?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its earnings per share growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- Revenue growth is close to the peer norm. Revenue growth: 3.3% vs peer median 6.1%
- faster revenue growth over three years: stronger than 88% of peers. 3-year revenue growth: 29.8% vs peer median 5.8%
- faster growth in earnings per share: stronger than 93% of peers. Earnings per share growth: 216.0% vs peer median 9.8%
Metric by metric
Position: dot = RIGL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RIGL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 451 reported | 3.3% | 4.1% | 47% | 33% | |
| Earnings per share growthHigher is better · 241 reported | 216.0% | 3.8% | 94% | 33% | |
| 3-year revenue growthHigher is better · 437 reported | 29.8% | 5.2% | 88% | 33% |
Ranking by growth score
Top 5 and the companies ranked around RIGL| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 885M USD | 99 | 33 | |
| 2 | 609M USD | 99 | 91 | |
| 39 | 1.8B USD | 89 | 52 | |
| 43 | 4.4B CNY (≈$618M) | 88 | 66 | |
| 43 | 782M USD | 88 | 35 | |
| 43 | 1.5B AUD (≈$982M) | 88 | 54 | |
| 43 | 913M USD | 88 | 77 | |
| 43 | 1.3B USD | 88 | 58 | |
| 48 | 2.9B SAR (≈$775M) | 87 | 66 | |
| 48 | 4.0B CNY (≈$554M) | 87 | 73 | |
| 48 | 1.8B USD | 87 | 80 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score